ID

22090

Beschreibung

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00336583

Link

https://clinicaltrials.gov/show/NCT00336583

Stichworte

  1. 19.05.17 19.05.17 -
Hochgeladen am

19. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-Hodgkin's Lymphoma NCT00336583

Eligibility Non-Hodgkin's Lymphoma NCT00336583

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
previously histologically confirmed aggressive lymphomas, defined according to who classification (except burkitt's lymphoma, lymphoblastic lymphoma)
Beschreibung

Aggressive Lymphoma WHO tumor classification | Burkitt Lymphoma | lymphoblastic lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1332225
UMLS CUI [1,2]
C1301142
UMLS CUI [2]
C0006413
UMLS CUI [3]
C0079748
failure to achieve a complete remission with the initial induction chemotherapy, or recurrent disease
Beschreibung

Induction Chemotherapy | complete remission failed | Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1]
C3179010
UMLS CUI [2,1]
C0677874
UMLS CUI [2,2]
C0231175
UMLS CUI [3]
C0277556
performance status (ecog) ≤3
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
age ≤ 75
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
treated with at least one chop or chop-derived doxorubicin containing regimen
Beschreibung

CHOP regimen | Doxorubicin CHOP Derived

Datentyp

boolean

Alias
UMLS CUI [1]
C0163868
UMLS CUI [2,1]
C0013089
UMLS CUI [2,2]
C0055598
UMLS CUI [2,3]
C1441547
at least one or more uni-dimensionally measurable lesion(s) defined as; ≥2 cm by conventional ct or ≥ 1 cm by spiral ct or skin lesion (photographs should be taken) or measurable lesion by physical examination
Beschreibung

Measurable lesion Linear Quantity | Lesion size X-Ray Computed Tomography | Lesion size Spiral Computed Tomography | Skin lesion Photograph | Measurable lesion Physical Examination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205132
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0449453
UMLS CUI [2,2]
C0040405
UMLS CUI [3,1]
C0449453
UMLS CUI [3,2]
C0860888
UMLS CUI [4,1]
C0037284
UMLS CUI [4,2]
C0441468
UMLS CUI [5,1]
C1513041
UMLS CUI [5,2]
C0031809
adequate organ functions defined as; anc > 1,500/ul, platelet > 75,000/ul, transaminases < 3 x upper normal values; bilirubin < 2 mg%
Beschreibung

Organ function | Absolute neutrophil count | Platelet Count measurement | Transaminases | Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0002594
UMLS CUI [5]
C1278039
written informed consent approved by institutional review board
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
Beschreibung

Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0851140
serious co-morbid diseases
Beschreibung

Comorbidity Serious

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
pregnancy or breast-feeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Ähnliche Modelle

Eligibility Non-Hodgkin's Lymphoma NCT00336583

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Aggressive Lymphoma WHO tumor classification | Burkitt Lymphoma | lymphoblastic lymphoma
Item
previously histologically confirmed aggressive lymphomas, defined according to who classification (except burkitt's lymphoma, lymphoblastic lymphoma)
boolean
C1332225 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0006413 (UMLS CUI [2])
C0079748 (UMLS CUI [3])
Induction Chemotherapy | complete remission failed | Recurrent disease
Item
failure to achieve a complete remission with the initial induction chemotherapy, or recurrent disease
boolean
C3179010 (UMLS CUI [1])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3])
ECOG performance status
Item
performance status (ecog) ≤3
boolean
C1520224 (UMLS CUI [1])
Age
Item
age ≤ 75
boolean
C0001779 (UMLS CUI [1])
CHOP regimen | Doxorubicin CHOP Derived
Item
treated with at least one chop or chop-derived doxorubicin containing regimen
boolean
C0163868 (UMLS CUI [1])
C0013089 (UMLS CUI [2,1])
C0055598 (UMLS CUI [2,2])
C1441547 (UMLS CUI [2,3])
Measurable lesion Linear Quantity | Lesion size X-Ray Computed Tomography | Lesion size Spiral Computed Tomography | Skin lesion Photograph | Measurable lesion Physical Examination
Item
at least one or more uni-dimensionally measurable lesion(s) defined as; ≥2 cm by conventional ct or ≥ 1 cm by spiral ct or skin lesion (photographs should be taken) or measurable lesion by physical examination
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0449453 (UMLS CUI [2,1])
C0040405 (UMLS CUI [2,2])
C0449453 (UMLS CUI [3,1])
C0860888 (UMLS CUI [3,2])
C0037284 (UMLS CUI [4,1])
C0441468 (UMLS CUI [4,2])
C1513041 (UMLS CUI [5,1])
C0031809 (UMLS CUI [5,2])
Organ function | Absolute neutrophil count | Platelet Count measurement | Transaminases | Serum total bilirubin measurement
Item
adequate organ functions defined as; anc > 1,500/ul, platelet > 75,000/ul, transaminases < 3 x upper normal values; bilirubin < 2 mg%
boolean
C0678852 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0002594 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
Informed Consent
Item
written informed consent approved by institutional review board
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Item
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Comorbidity Serious
Item
serious co-morbid diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video